Quinazolinone compounds

Phosphate derivatives are disclosed of quinazolinone compounds having structural formula (I) or a pharmaceutically acceptable salt thereof, wherein X' represent hydroxyl, alkyl, alkoxy, or O-Z where Z is a phosphate or phosphate derivative; Y' represents hydrogen, alkyl or an optionally su...

Full description

Saved in:
Bibliographic Details
Main Authors NEWELL, DAVID, RICHARD, GRIFFIN, ROGER, JOHN, CURTIN, NICOLA, JANE, GOLDING, BERNARD, THOMAS, CALVERT, ALAN, HILARY
Format Patent
LanguageEnglish
French
German
Published 04.09.2002
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Phosphate derivatives are disclosed of quinazolinone compounds having structural formula (I) or a pharmaceutically acceptable salt thereof, wherein X' represent hydroxyl, alkyl, alkoxy, or O-Z where Z is a phosphate or phosphate derivative; Y' represents hydrogen, alkyl or an optionally substituted aryl group or optionally substituted aralkyl group; and R' is hydrogen, alkyl, or CH2-O-Z where Z is again a phosphate or phosphate derivative; subject to the proviso that if neither X' nor R' contains Z, Y' is an aryl or aralkyl group having an O-Z substituent therein with Z once again being a phosphate or phosphate derivative as hereinabove defined. These compounds are useful as prodrugs for providing active PARP inhibiting substances for medical use in conjunction with a cytotoxic drug or radiotherapy in order to increase the effectiveness of the latter, especially in connection with antitumor treatment.
Bibliography:Application Number: EP19980902115